Free Trial

Envista (NVST) Competitors

Envista logo
$20.14 -0.16 (-0.76%)
As of 10:10 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NVST vs. BRBR, SOLV, PEN, STVN, GKOS, IRTC, BLCO, TMDX, SLNO, and LIVN

Should you be buying Envista stock or one of its competitors? The main competitors of Envista include BellRing Brands (BRBR), Solventum (SOLV), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), and LivaNova (LIVN).

Envista vs. Its Competitors

Envista (NYSE:NVST) and BellRing Brands (NYSE:BRBR) are related mid-cap companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Envista has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500. Comparatively, BellRing Brands has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500.

Envista presently has a consensus target price of $20.92, indicating a potential upside of 3.86%. BellRing Brands has a consensus target price of $64.80, indicating a potential upside of 54.27%. Given BellRing Brands' stronger consensus rating and higher probable upside, analysts clearly believe BellRing Brands is more favorable than Envista.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Envista
1 Sell rating(s)
9 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.33
BellRing Brands
0 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.87

In the previous week, BellRing Brands had 14 more articles in the media than Envista. MarketBeat recorded 26 mentions for BellRing Brands and 12 mentions for Envista. Envista's average media sentiment score of 1.26 beat BellRing Brands' score of 1.07 indicating that Envista is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Envista
9 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
BellRing Brands
12 Very Positive mention(s)
0 Positive mention(s)
13 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

BellRing Brands has lower revenue, but higher earnings than Envista. BellRing Brands is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Envista$2.55B1.31-$1.12B$0.3262.95
BellRing Brands$2.22B2.38$246.50M$1.7524.00

95.0% of BellRing Brands shares are held by institutional investors. 0.7% of Envista shares are held by insiders. Comparatively, 1.1% of BellRing Brands shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

BellRing Brands has a net margin of 10.26% compared to Envista's net margin of 2.11%. Envista's return on equity of 4.84% beat BellRing Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Envista2.11% 4.84% 2.68%
BellRing Brands 10.26%-123.43%30.88%

Summary

BellRing Brands beats Envista on 11 of the 17 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVST and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVST vs. The Competition

MetricEnvistaMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$3.37B$10.80B$5.75B$21.20B
Dividend YieldN/A1.84%6.66%3.49%
P/E Ratio63.2821.6182.7629.24
Price / Sales1.3128.42505.2147.07
Price / Cash12.7525.1325.7018.29
Price / Book1.073.3810.815.27
Net Income-$1.12B$211.94M$3.28B$998.51M
7 Day Performance-5.20%-3.34%-0.28%-0.54%
1 Month Performance-1.62%7.92%8.49%5.01%
1 Year Performance16.99%-8.32%50.80%14.12%

Envista Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVST
Envista
3.8035 of 5 stars
$20.15
-0.8%
$20.92
+3.9%
+13.9%$3.37B$2.55B63.2812,300Positive News
BRBR
BellRing Brands
4.3895 of 5 stars
$41.04
+0.4%
$64.80
+57.9%
-24.6%$5.17B$2.00B18.92380Positive News
Buyback Announcement
SOLV
Solventum
2.4601 of 5 stars
$73.15
+0.7%
$85.75
+17.2%
+11.7%$12.67B$8.25B13.0722,000Analyst Upgrade
PEN
Penumbra
4.8317 of 5 stars
$272.96
+0.5%
$300.47
+10.1%
+31.8%$10.63B$1.19B72.604,500News Coverage
Positive News
Analyst Forecast
STVN
Stevanato Group
N/A€23.14
-1.4%
N/A+6.6%€7.01B€1.19B42.855,521Positive News
GKOS
Glaukos
4.7816 of 5 stars
$95.86
-0.7%
$127.42
+32.9%
-29.0%$5.50B$383.48M-58.10780Positive News
IRTC
iRhythm Technologies
1.5893 of 5 stars
$169.98
-0.9%
$163.82
-3.6%
+159.7%$5.46B$591.84M-58.012,000Positive News
BLCO
Bausch + Lomb
2.2549 of 5 stars
$14.63
+0.6%
$15.56
+6.3%
-9.8%$5.18B$4.79B34.8313,500Positive News
TMDX
TransMedics Group
3.1764 of 5 stars
$114.96
-1.5%
$123.00
+7.0%
-32.9%$3.92B$441.54M59.56210Positive News
SLNO
Soleno Therapeutics
4.5589 of 5 stars
$67.67
-1.1%
$115.09
+70.1%
+41.6%$3.60BN/A-16.3530News Coverage
LIVN
LivaNova
1.7264 of 5 stars
$56.37
+1.7%
$59.71
+5.9%
+14.1%$3.08B$1.25B-14.492,900News Coverage
Positive News
Analyst Forecast

Related Companies and Tools


This page (NYSE:NVST) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners